id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02286687 | 1:38:treatment | Prior treatment with a PARP inhibitor | 3 | [
"Prior",
"treatment",
"with",
"a",
"PARP",
"inhibitor"
] | [
1,
1,
1,
1,
1,
1
] |
NCT01953900 | 42:56:allergy_name | History of hypersensitivity reactions to murine protein-containing products | 3 | [
"History",
"of",
"hypersensitivity",
"reactions",
"to",
"murine",
"protein-containing",
"products"
] | [
0,
0,
0,
0,
0,
4,
4,
0
] |
NCT02891564 | 27:30:treatment | ability to participate in MRI | 3 | [
"ability",
"to",
"participate",
"in",
"MRI"
] | [
0,
0,
0,
0,
1
] |
NCT02966665 | 1:25:chronic_disease | Unstable angina pectoris | 3 | [
"Unstable",
"angina",
"pectoris"
] | [
2,
2,
2
] |
NCT02462161 | 1:14:chronic_disease | liver disease | 3 | [
"liver",
"disease"
] | [
2,
2
] |
NCT01200940 | ,24:46:treatment | alter gastric pH (e.g. proton pump inhibitors) | 3 | [
"alter",
"gastric",
"pH",
"(",
"e.g",
".",
"proton",
"pump",
"inhibitors",
")"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
0
] |
NCT01087294 | ,,173:191:treatment | Patients of childbearing or child-fathering potential must be willing use an effective method of contraception while being treated on this study and for 4 months after the last cell infusion | 3 | [
"Patients",
"of",
"childbearing",
"or",
"child-fathering",
"potential",
"must",
"be",
"willing",
"use",
"an",
"effective",
"method",
"of",
"contraception",
"while",
"being",
"treated",
"on",
"this",
"study",
"and",
"for",
"4",
"months",
"after",
"the",
"last",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02953431 | 7:22:chronic_disease | Known aortic aneurysm | 3 | [
"Known",
"aortic",
"aneurysm"
] | [
0,
2,
2
] |
NCT02495415 | 33:50:chronic_disease,,,, | Patients with poorly controlled diabetes mellitus with fasting serum glucose concentration over 200 mg/dl or a hemoglobin A1C over 7.5% | 3 | [
"Patients",
"with",
"poorly",
"controlled",
"diabetes",
"mellitus",
"with",
"fasting",
"serum",
"glucose",
"concentration",
"over",
"200",
"mg/dl",
"or",
"a",
"hemoglobin",
"A1C",
"over",
"7.5",
"%"
] | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02547662 | 95:117:chronic_disease,119:138:chronic_disease,142:154:chronic_disease | Other co-morbidity which would interfere with patient's ability to participate in trial, e.g. uncontrolled infection, uncompensated heart or lung disease | 3 | [
"Other",
"co-morbidity",
"which",
"would",
"interfere",
"with",
"patient",
"'s",
"ability",
"to",
"participate",
"in",
"trial",
",",
"e.g",
".",
"uncontrolled",
"infection",
",",
"uncompensated",
"heart",
"or",
"lung",
"disease"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2
] |
NCT02111850 | 18:51:treatment | Subjects must be co-enrolled in protocol 03-C-0277 | 3 | [
"Subjects",
"must",
"be",
"co-enrolled",
"in",
"protocol",
"03-C-0277"
] | [
0,
0,
0,
1,
1,
1,
1
] |
NCT02091999 | 12:32:treatment, | Use of any investigational drug within 14 days prior to the first dose of study drug | 3 | [
"Use",
"of",
"any",
"investigational",
"drug",
"within",
"14",
"days",
"prior",
"to",
"the",
"first",
"dose",
"of",
"study",
"drug"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00291525 | 18:28:treatment | Patients with an On-X valve implanted within the study and subsequently explanted | 3 | [
"Patients",
"with",
"an",
"On-X",
"valve",
"implanted",
"within",
"the",
"study",
"and",
"subsequently",
"explanted"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT03186937 | 41:66:treatment,54:66:treatment,121:134:treatment | Participants who are planned to undergo neo-adjuvant chemotherapy are eligible as long as they consent to an additional breast biopsy following the dietary intervention immediately prior to starting chemotherapy | 3 | [
"Participants",
"who",
"are",
"planned",
"to",
"undergo",
"neo-adjuvant",
"chemotherapy",
"are",
"eligible",
"as",
"long",
"as",
"they",
"consent",
"to",
"an",
"additional",
"breast",
"biopsy",
"following",
"the",
"dietary",
"intervention",
"immediately",
"prior",
... | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02421315 | 1:16:chronic_disease | eating disorder | 3 | [
"eating",
"disorder"
] | [
2,
2
] |
NCT02308904 | 6:17:chronic_disease | with thalassemia (any genotype) | 3 | [
"with",
"thalassemia",
"(",
"any",
"genotype",
")"
] | [
0,
2,
0,
0,
0,
0
] |
NCT02547662 | 62:85:treatment | All study participants must be registered into the mandatory pomalidomide (POMALYST) Risk Evaluation and Mitigation Strategy (REMS) program, and be willing and able to comply with the requirements of the POMALYST REMS program | 3 | [
"All",
"study",
"participants",
"must",
"be",
"registered",
"into",
"the",
"mandatory",
"pomalidomide",
"(",
"POMALYST",
")",
"Risk",
"Evaluation",
"and",
"Mitigation",
"Strategy",
"(",
"REMS",
")",
"program",
",",
"and",
"be",
"willing",
"and",
"able",
"to",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02497300 | 8:26:chronic_disease,, | Severe hypertension (HTN) (office BP ≥ 160/100 mm Hg) | 3 | [
"Severe",
"hypertension",
"(",
"HTN",
")",
"(",
"office",
"BP",
"≥",
"160/100",
"mm",
"Hg",
")"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02215096 | 55:79:chronic_disease,81:105:chronic_disease,107:131:chronic_disease,133:152:chronic_disease | History of congenital platelet function defect (e.g., Bernard-Soulier syndrome, Chediak-Higashi syndrome, Glanzmann thrombasthenia, storage pool defect) | 3 | [
"History",
"of",
"congenital",
"platelet",
"function",
"defect",
"(",
"e.g.",
",",
"Bernard-Soulier",
"syndrome",
",",
"Chediak-Higashi",
"syndrome",
",",
"Glanzmann",
"thrombasthenia",
",",
"storage",
"pool",
"defect",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0
] |
NCT03127722 | 18:63:chronic_disease | Subjects with an active upper or lower genital tract infection | 3 | [
"Subjects",
"with",
"an",
"active",
"upper",
"or",
"lower",
"genital",
"tract",
"infection"
] | [
0,
0,
0,
2,
2,
2,
2,
2,
2,
2
] |
NCT02435069 | 19:43:treatment | those who require prophylactic antibiotics | 3 | [
"those",
"who",
"require",
"prophylactic",
"antibiotics"
] | [
0,
0,
0,
1,
1
] |
NCT02178566 | 9:30:treatment | Planned surgical intervention during the study period | 3 | [
"Planned",
"surgical",
"intervention",
"during",
"the",
"study",
"period"
] | [
0,
1,
1,
0,
0,
0,
0
] |
NCT01627821 | 10:23:chronic_disease,64:79:chronic_disease,81:92:chronic_disease,95:121:chronic_disease,123:142:chronic_disease,144:155:chronic_disease,157:172:chronic_disease,177:195:chronic_disease | Cause of heart failure due to, or associated with, uncorrected thyroid disease, obstructive / restrictive cardiomyopathy, pericardial disease, amyloidosis, dermatomyositis, or active myocarditis | 3 | [
"Cause",
"of",
"heart",
"failure",
"due",
"to",
",",
"or",
"associated",
"with",
",",
"uncorrected",
"thyroid",
"disease",
",",
"obstructive",
"/",
"restrictive",
"cardiomyopathy",
",",
"pericardial",
"disease",
",",
"amyloidosis",
",",
"dermatomyositis",
",",
"... | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
2,
0,
2,
2,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT01438073 | ,,20:49:chronic_disease | Men and women with hypogonadotropic hypogonadism | 3 | [
"Men",
"and",
"women",
"with",
"hypogonadotropic",
"hypogonadism"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02383927 | 13:43:chronic_disease, | evidence of unstable neurological symptoms within 4 weeks first dose | 3 | [
"evidence",
"of",
"unstable",
"neurological",
"symptoms",
"within",
"4",
"weeks",
"first",
"dose"
] | [
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02595866 | 8:29:chronic_disease, | recent myocardial infarction (within the last 6 months) | 3 | [
"recent",
"myocardial",
"infarction",
"(",
"within",
"the",
"last",
"6",
"months",
")"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02485418 | 4:30:treatment, | No ergot alkaloid derivatives within the last 24 hours | 3 | [
"No",
"ergot",
"alkaloid",
"derivatives",
"within",
"the",
"last",
"24",
"hours"
] | [
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02433158 | 32:42:treatment | Diagnosis of VOC necessitating IV opioids and admission to the hospital | 3 | [
"Diagnosis",
"of",
"VOC",
"necessitating",
"IV",
"opioids",
"and",
"admission",
"to",
"the",
"hospital"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02565901 | 9:98:treatment,100:111:treatment,115:126:treatment | Ongoing gonadal androgen deprivation therapy with gonadotropin-releasing hormone (GnRH) analogues, antagonists or orchiectomy | 3 | [
"Ongoing",
"gonadal",
"androgen",
"deprivation",
"therapy",
"with",
"gonadotropin-releasing",
"hormone",
"(",
"GnRH",
")",
"analogues",
",",
"antagonists",
"or",
"orchiectomy"
] | [
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
1
] |
NCT03144245 | 1:26:cancer, | Second primary malignancy that has not been in remission for greater than 3 years | 3 | [
"Second",
"primary",
"malignancy",
"that",
"has",
"not",
"been",
"in",
"remission",
"for",
"greater",
"than",
"3",
"years"
] | [
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01841333 | 34:64:chronic_disease | Without clinical signs of active central nervous system disease | 3 | [
"Without",
"clinical",
"signs",
"of",
"active",
"central",
"nervous",
"system",
"disease"
] | [
0,
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT02584309 | 13:35:chronic_disease | Symptomatic valvular heart disease | 3 | [
"Symptomatic",
"valvular",
"heart",
"disease"
] | [
0,
2,
2,
2
] |
NCT02473250 | 1:22:treatment,26:49:treatment,61:68:treatment | Current anticoagulant or anti-platelet treatment other than aspirin | 3 | [
"Current",
"anticoagulant",
"or",
"anti-platelet",
"treatment",
"other",
"than",
"aspirin"
] | [
1,
1,
0,
1,
1,
0,
0,
1
] |
NCT02566304 | 1:29:cancer | Myeloproliferative disorders | 3 | [
"Myeloproliferative",
"disorders"
] | [
3,
3
] |
NCT01553071 | 28:43:treatment,49:80:treatment,69:80:treatment | Patients who have received prior treatment with oral or intravenous fenretinide as a single agent are eligible, provided they did not experience severe toxicity related to fenretinide | 3 | [
"Patients",
"who",
"have",
"received",
"prior",
"treatment",
"with",
"oral",
"or",
"intravenous",
"fenretinide",
"as",
"a",
"single",
"agent",
"are",
"eligible",
",",
"provided",
"they",
"did",
"not",
"experience",
"severe",
"toxicity",
"related",
"to",
"fenreti... | [
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02498951 | 14:23:chronic_disease,25:30:chronic_disease,32:38:chronic_disease,40:53:chronic_disease,64:73:chronic_disease,85:102:chronic_disease,161:190:treatment,179:190:treatment,194:209:treatment, | Known active bacterial, viral, fungal, mycobacterial, or other infection (excluding fungal infections of nail beds) or any major episode of infection requiring treatment with IV antibiotics or hospitalization (related to the completion of the course of antibiotics) within 4 weeks prior to study enrollment | 3 | [
"Known",
"active",
"bacterial",
",",
"viral",
",",
"fungal",
",",
"mycobacterial",
",",
"or",
"other",
"infection",
"(",
"excluding",
"fungal",
"infections",
"of",
"nail",
"beds",
")",
"or",
"any",
"major",
"episode",
"of",
"infection",
"requiring",
"treatment... | [
0,
0,
2,
0,
2,
0,
2,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02543944 | 23:60:treatment,72:78:treatment,119:130:treatment | report ongoing use of over-the-counter or prescription drug (including Maalox) that would have major interaction with study drugs | 3 | [
"report",
"ongoing",
"use",
"of",
"over-the-counter",
"or",
"prescription",
"drug",
"(",
"including",
"Maalox",
")",
"that",
"would",
"have",
"major",
"interaction",
"with",
"study",
"drugs"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01962415 | 1:46:treatment, | Allogeneic hematopoietic stem cell transplant within the previous 6 months | 3 | [
"Allogeneic",
"hematopoietic",
"stem",
"cell",
"transplant",
"within",
"the",
"previous",
"6",
"months"
] | [
1,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02650206 | 1:22:chronic_disease,, | Unstable hypertension (BP >160/100 mm Hg) | 3 | [
"Unstable",
"hypertension",
"(",
"BP",
">",
"160/100",
"mm",
"Hg",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03103490 | 33:52:chronic_disease | Patient with known or suspected cardiac sarcoidosis | 3 | [
"Patient",
"with",
"known",
"or",
"suspected",
"cardiac",
"sarcoidosis"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT02960555 | 140:167:cancer | Immunoparesis (this term refers to the patient having low uninvolved immunoglobulins in peripheral blood, for example if a patient has IgA smoldering multiple myeloma, then either having a low IgM and/or low IgG will qualify as a risk factor for progression to multiple myeloma) | 3 | [
"Immunoparesis",
"(",
"this",
"term",
"refers",
"to",
"the",
"patient",
"having",
"low",
"uninvolved",
"immunoglobulins",
"in",
"peripheral",
"blood",
",",
"for",
"example",
"if",
"a",
"patient",
"has",
"IgA",
"smoldering",
"multiple",
"myeloma",
",",
"then",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02282462 | 12:25:treatment | undergoing pneumonectomy | 3 | [
"undergoing",
"pneumonectomy"
] | [
0,
1
] |
NCT02346201 | 14:29:chronic_disease | Uncontrolled hyperthyroidism | 3 | [
"Uncontrolled",
"hyperthyroidism"
] | [
0,
2
] |
NCT02064036 | ,25:40:treatment | 10-day period following prostate biopsy | 3 | [
"10-day",
"period",
"following",
"prostate",
"biopsy"
] | [
0,
0,
0,
1,
1
] |
NCT02632422 | 1:25:chronic_disease | spinal cord injury (SCI) at or below C3 (phrenic sparing) | 3 | [
"spinal",
"cord",
"injury",
"(",
"SCI",
")",
"at",
"or",
"below",
"C3",
"(",
"phrenic",
"sparing",
")"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02544373 | 14:36:chronic_disease | Diagnosis of clinically definite MS | 3 | [
"Diagnosis",
"of",
"clinically",
"definite",
"MS"
] | [
0,
0,
2,
2,
2
] |
NCT03129061 | 1:42:treatment | Prior exposure to PD-1 or PD-LI treatment | 3 | [
"Prior",
"exposure",
"to",
"PD-1",
"or",
"PD-LI",
"treatment"
] | [
1,
1,
1,
1,
1,
1,
1
] |
NCT00903266 | 48:60:chronic_disease,64:84:chronic_disease,91:99:chronic_disease,101:111:chronic_disease,113:125:chronic_disease | a terminal medical condition; history of major neurological or psychiatric diseases (e.g. epilepsy; meningitis, encephalitis) | 3 | [
"a",
"terminal",
"medical",
"condition",
";",
"history",
"of",
"major",
"neurological",
"or",
"psychiatric",
"diseases",
"(",
"e.g",
".",
"epilepsy",
";",
"meningitis",
",",
"encephalitis",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
2,
0,
2,
0,
2,
0
] |
NCT01555905 | 22:49:chronic_disease | Clinical evidence of impaired pulmonary function | 3 | [
"Clinical",
"evidence",
"of",
"impaired",
"pulmonary",
"function"
] | [
0,
0,
0,
2,
2,
2
] |
NCT02398773 | 26:50:cancer | Histologically confirmed metastatic breast cancer | 3 | [
"Histologically",
"confirmed",
"metastatic",
"breast",
"cancer"
] | [
0,
0,
3,
3,
3
] |
NCT00862433 | 20:28:chronic_disease,37:50:chronic_disease,52:71:chronic_disease,,,97:107:chronic_disease,109:134:chronic_disease,137:156:chronic_disease,158:181:chronic_disease,186:213:chronic_disease | Complications from diabetes such as kidney damage (renal insufficiency, serum creatinine >1.8), eye damage (proliferative retinopathy), diabetic neuropathy, coronary artery disease, or peripheral vascular disease | 3 | [
"Complications",
"from",
"diabetes",
"such",
"as",
"kidney",
"damage",
"(",
"renal",
"insufficiency",
",",
"serum",
"creatinine",
">",
"1.8",
")",
",",
"eye",
"damage",
"(",
"proliferative",
"retinopathy",
")",
",",
"diabetic",
"neuropathy",
",",
"coronary",
"... | [
0,
0,
2,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
2,
2,
2
] |
NCT02484404 | 69:105:cancer | Patients must have histologically confirmed persistent or recurrent triple-negative breast cancer (TNBC) | 3 | [
"Patients",
"must",
"have",
"histologically",
"confirmed",
"persistent",
"or",
"recurrent",
"triple-negative",
"breast",
"cancer",
"(",
"TNBC",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0
] |
NCT03085147 | 27:35:allergy_name | Known hypersensitivity to Olaparib | 3 | [
"Known",
"hypersensitivity",
"to",
"Olaparib"
] | [
0,
0,
0,
4
] |
NCT01625234 | 20:38:treatment, | Concomitant use of herbal medications at least 7 days prior to the first dose of study drug and throughout participation in the trial | 3 | [
"Concomitant",
"use",
"of",
"herbal",
"medications",
"at",
"least",
"7",
"days",
"prior",
"to",
"the",
"first",
"dose",
"of",
"study",
"drug",
"and",
"throughout",
"participation",
"in",
"the",
"trial"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02573883 | 12:37:treatment | History of transvaginal mesh implant | 3 | [
"History",
"of",
"transvaginal",
"mesh",
"implant"
] | [
0,
0,
1,
1,
1
] |
NCT02177292 | 1:15:cancer | adenocarcinoma of the prostate | 3 | [
"adenocarcinoma",
"of",
"the",
"prostate"
] | [
3,
0,
0,
0
] |
NCT01241708 | 14:23:chronic_disease,25:30:chronic_disease,32:38:chronic_disease,42:62:chronic_disease | Uncontrolled bacterial, viral, fungal or parasitic infections | 3 | [
"Uncontrolled",
"bacterial",
",",
"viral",
",",
"fungal",
"or",
"parasitic",
"infections"
] | [
0,
2,
0,
2,
0,
2,
0,
2,
2
] |
NCT02656550 | 20:42:treatment | Willing to undergo in-vitro fertilization | 3 | [
"Willing",
"to",
"undergo",
"in-vitro",
"fertilization"
] | [
0,
0,
0,
1,
1
] |
NCT02593123 | 43:92:treatment | The consent form must be signed and dated prior to initiation of SCT preparative treatments | 3 | [
"The",
"consent",
"form",
"must",
"be",
"signed",
"and",
"dated",
"prior",
"to",
"initiation",
"of",
"SCT",
"preparative",
"treatments"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1
] |
NCT02350764 | 23:26:chronic_disease,27:30:chronic_disease,34:39:chronic_disease | Any positive test for HCV RNA or HBsAg | 3 | [
"Any",
"positive",
"test",
"for",
"HCV",
"RNA",
"or",
"HBsAg"
] | [
0,
0,
0,
0,
2,
2,
0,
2
] |
NCT02130687 | 1:26:chronic_disease,,, | Impaired hepatic function (aspartate amino transaminase [AST] and/or alanine amino transaminase [ALT] >3 x upper limit of normal range) | 3 | [
"Impaired",
"hepatic",
"function",
"(",
"aspartate",
"amino",
"transaminase",
"[",
"AST",
"]",
"and/or",
"alanine",
"amino",
"transaminase",
"[",
"ALT",
"]",
">",
"3",
"x",
"upper",
"limit",
"of",
"normal",
"range",
")"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01553942 | 33:61:chronic_disease | History or presence of relevant cardiovascular abnormalities | 3 | [
"History",
"or",
"presence",
"of",
"relevant",
"cardiovascular",
"abnormalities"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT01349101 | 19:25:cancer,27:36:cancer,41:48:cancer,,160:167:treatment,232:241:treatment | For patients with RAEB-1, RCMD+/-RS, or MDS NOS must have stable disease for 6 months (as documented by serial bone marrow examinations) in the absence of any therapy but growth factors or transfusion support. Patients who require treatment to control their disease must show chemo-responsiveness | 3 | [
"For",
"patients",
"with",
"RAEB-1",
",",
"RCMD+/-RS",
",",
"or",
"MDS",
"NOS",
"must",
"have",
"stable",
"disease",
"for",
"6",
"months",
"(",
"as",
"documented",
"by",
"serial",
"bone",
"marrow",
"examinations",
")",
"in",
"the",
"absence",
"of",
"any",
... | [
0,
0,
0,
3,
0,
3,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01050855 | 14:23:chronic_disease,25:31:chronic_disease,41:51:chronic_disease | Uncontrolled bacterial, fungal or viral infections | 3 | [
"Uncontrolled",
"bacterial",
",",
"fungal",
"or",
"viral",
"infections"
] | [
0,
2,
0,
2,
0,
0,
2
] |
NCT02057133 | ,78:102:cancer | Have a diagnosis of human epidermal growth factor receptor 2 (HER2) positive metastatic breast cancer for Parts F and H | 3 | [
"Have",
"a",
"diagnosis",
"of",
"human",
"epidermal",
"growth",
"factor",
"receptor",
"2",
"(",
"HER2",
")",
"positive",
"metastatic",
"breast",
"cancer",
"for",
"Parts",
"F",
"and",
"H"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT01474889 | 1:8:treatment, | Insulin requirement of more than 1.0 IU/kg/day | 3 | [
"Insulin",
"requirement",
"of",
"more",
"than",
"1.0",
"IU/kg/day"
] | [
1,
0,
0,
0,
0,
0,
0
] |
NCT02637947 | 26:52:treatment | subject has had previous thoracic radiation therapy | 3 | [
"subject",
"has",
"had",
"previous",
"thoracic",
"radiation",
"therapy"
] | [
0,
0,
0,
0,
1,
1,
1
] |
NCT02613585 | 16:28:allergy_name | sensitivity to insecticides | 3 | [
"sensitivity",
"to",
"insecticides"
] | [
0,
0,
4
] |
NCT02056873 | 12:22:treatment,,,,294:305:treatment,,323:331:treatment,333:344:treatment,,363:375:treatment,, | TS must be medication refractory. Criteria to determine if medication refractory is the exact criteria stated by Mink et. al TSA DBS Guidelines published in 2006: Subjects must have been treated by a psychiatrist or neurologist experienced in TS with therapeutic doses of either 1-4 mg/day of haloperidol or 2-8 mg/day o... | 3 | [
"TS",
"must",
"be",
"medication",
"refractory",
".",
"Criteria",
"to",
"determine",
"if",
"medication",
"refractory",
"is",
"the",
"exact",
"criteria",
"stated",
"by",
"Mink",
"et",
".",
"al",
"TSA",
"DBS",
"Guidelines",
"published",
"in",
"2006",
":",
"Subj... | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0... |
NCT02378714 | 6:13:chronic_disease, | high suicide risk based on the Columbia Suicide Severity Rating Scale | 3 | [
"high",
"suicide",
"risk",
"based",
"on",
"the",
"Columbia",
"Suicide",
"Severity",
"Rating",
"Scale"
] | [
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02374021 | 1:6:allergy_name | sulfa allergy | 3 | [
"sulfa",
"allergy"
] | [
4,
0
] |
NCT02516969 | 16:36:cancer,47:65:treatment,82:94:treatment | second-primary head-and-neck cancer receiving prior radiotherapy with or without chemotherapy | 3 | [
"second-primary",
"head-and-neck",
"cancer",
"receiving",
"prior",
"radiotherapy",
"with",
"or",
"without",
"chemotherapy"
] | [
0,
3,
3,
0,
1,
1,
0,
0,
0,
1
] |
NCT01696734 | 1:23:chronic_disease | sinus node dysfunction | 3 | [
"sinus",
"node",
"dysfunction"
] | [
2,
2,
2
] |
NCT02349035 | 1:21:chronic_disease | Cognitive impairment sufficient to adversely affect understanding of or compliance with study requirements | 3 | [
"Cognitive",
"impairment",
"sufficient",
"to",
"adversely",
"affect",
"understanding",
"of",
"or",
"compliance",
"with",
"study",
"requirements"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03015805 | 1:35:chronic_disease | Severe/profound mental retardation | 3 | [
"Severe/profound",
"mental",
"retardation"
] | [
2,
2,
2
] |
NCT00085982 | 8:27:treatment | Use of anorexiogenic drugs | 3 | [
"Use",
"of",
"anorexiogenic",
"drugs"
] | [
0,
0,
1,
1
] |
NCT01876511 | 26:71:treatment | Patients with history of allogeneic hematopoeitic stem cell transplant | 3 | [
"Patients",
"with",
"history",
"of",
"allogeneic",
"hematopoeitic",
"stem",
"cell",
"transplant"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT02503709 | 39:46:treatment,161:185:treatment,216:224:chronic_disease | There are no limits on prior lines of therapy; however, patients must have recovered to eligibility levels from prior toxicity or adverse events as a result of previous treatment prior to entering the study (except alopecia) | 3 | [
"There",
"are",
"no",
"limits",
"on",
"prior",
"lines",
"of",
"therapy",
";",
"however",
",",
"patients",
"must",
"have",
"recovered",
"to",
"eligibility",
"levels",
"from",
"prior",
"toxicity",
"or",
"adverse",
"events",
"as",
"a",
"result",
"of",
"previous... | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT02460783 | 23:37:chronic_disease,, | untreated subclinical hypothyroidism with TSH < 10 mU/l or successfully treated hypothyroidism may be allowed | 3 | [
"untreated",
"subclinical",
"hypothyroidism",
"with",
"TSH",
"<",
"10",
"mU/l",
"or",
"successfully",
"treated",
"hypothyroidism",
"may",
"be",
"allowed"
] | [
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02900469 | 15:46:chronic_disease | Patients with active dental or jaw conditions which require oral surgery/dental procedures, including tooth extraction for the course of the study | 3 | [
"Patients",
"with",
"active",
"dental",
"or",
"jaw",
"conditions",
"which",
"require",
"oral",
"surgery/dental",
"procedures",
",",
"including",
"tooth",
"extraction",
"for",
"the",
"course",
"of",
"the",
"study"
] | [
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02495415 | 23:47:treatment, | Patients who have had major non-biopsy surgery in the last 20 days | 3 | [
"Patients",
"who",
"have",
"had",
"major",
"non-biopsy",
"surgery",
"in",
"the",
"last",
"20",
"days"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT03002571 | 45:54:chronic_disease,56:63:chronic_disease,65:77:chronic_disease,82:92:chronic_disease,105:124:chronic_disease | History of confounding skin conditions, eg, psoriasis, rosacea, erythroderma, or ichthyosis (other than ichthyosis vulgaris) | 3 | [
"History",
"of",
"confounding",
"skin",
"conditions",
",",
"eg",
",",
"psoriasis",
",",
"rosacea",
",",
"erythroderma",
",",
"or",
"ichthyosis",
"(",
"other",
"than",
"ichthyosis",
"vulgaris",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02437370 | 14:181:treatment,173:181:treatment,193:203:treatment,229:233:treatment | Has received prior therapy with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-cluster of differentiation (CD)137, or anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways) | 3 | [
"Has",
"received",
"prior",
"therapy",
"with",
"an",
"anti-PD-1",
",",
"anti-PD-L1",
",",
"anti-PD-L2",
",",
"anti-cluster",
"of",
"differentiation",
"(",
"CD",
")",
"137",
",",
"or",
"anti-cytotoxic",
"T-lymphocyte-associated",
"antigen-4",
"(",
"CTLA-4",
")",
... | [
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02193373 | 9:31:chronic_disease,63:87:chronic_disease,98:119:chronic_disease,125:139:chronic_disease,145:155:chronic_disease,169:184:treatment | Chronic Cardiovascular Disease (including but not limited to: congestive heart failure, previous myocardial infarction, any cardiomyopathy, any arrhythmia, or previous cardiac surgery) | 3 | [
"Chronic",
"Cardiovascular",
"Disease",
"(",
"including",
"but",
"not",
"limited",
"to",
":",
"congestive",
"heart",
"failure",
",",
"previous",
"myocardial",
"infarction",
",",
"any",
"cardiomyopathy",
",",
"any",
"arrhythmia",
",",
"or",
"previous",
"cardiac",
... | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
2,
2,
0,
0,
2,
0,
0,
2,
0,
0,
0,
1,
1,
0
] |
NCT02549937 | 1:17:cancer,25:48:chronic_disease,64:71:treatment,79:91:treatment,134:148:cancer,,191:199:treatment,,233:248:treatment | Brain metastases and/or spinal cord compression untreated with surgery and/or radiotherapy, and without clinical imaging evidence of stable disease for 14 days or longer; Subjects requiring steroids within 4 weeks prior to start of study treatment | 3 | [
"Brain",
"metastases",
"and/or",
"spinal",
"cord",
"compression",
"untreated",
"with",
"surgery",
"and/or",
"radiotherapy",
",",
"and",
"without",
"clinical",
"imaging",
"evidence",
"of",
"stable",
"disease",
"for",
"14",
"days",
"or",
"longer",
";",
"Subjects",
... | [
3,
3,
0,
2,
2,
2,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02417701 | 1:20:chronic_disease | torsades de pointes | 3 | [
"torsades",
"de",
"pointes"
] | [
2,
2,
2
] |
NCT02867124 | 1:23:chronic_disease,69:86:chronic_disease,88:101:chronic_disease | Active medical illness that may make participation hazardous (e.g., unstable diabetes, heart disease). Adequately treated medical conditions are acceptable | 3 | [
"Active",
"medical",
"illness",
"that",
"may",
"make",
"participation",
"hazardous",
"(",
"e.g.",
",",
"unstable",
"diabetes",
",",
"heart",
"disease",
")",
".",
"Adequately",
"treated",
"medical",
"conditions",
"are",
"acceptable"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01464164 | 1:14:chronic_disease,, | Heart disease (NY Heart Association classification of >/= 3 | 3 | [
"Heart",
"disease",
"(",
"NY",
"Heart",
"Association",
"classification",
"of",
">",
"/=",
"3"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03050801 | 12:32:chronic_disease | History of mild to moderate TBI | 3 | [
"History",
"of",
"mild",
"to",
"moderate",
"TBI"
] | [
0,
0,
2,
2,
2,
2
] |
NCT02085941 | 48:51:treatment | must have a mass that is well-visualized under MRI | 3 | [
"must",
"have",
"a",
"mass",
"that",
"is",
"well-visualized",
"under",
"MRI"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02575404 | 28:39:chronic_disease,41:49:chronic_disease,130:173:treatment | Unresolved immune-mediated pneumonitis, diarrhea, elevation of hepatocellular enzymes or other toxicities requiring greater than physiological replacement doses of steroids | 3 | [
"Unresolved",
"immune-mediated",
"pneumonitis",
",",
"diarrhea",
",",
"elevation",
"of",
"hepatocellular",
"enzymes",
"or",
"other",
"toxicities",
"requiring",
"greater",
"than",
"physiological",
"replacement",
"doses",
"of",
"steroids"
] | [
0,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT02273375 | 34:46:cancer | Patients with a history of other malignancies | 3 | [
"Patients",
"with",
"a",
"history",
"of",
"other",
"malignancies"
] | [
0,
0,
0,
0,
0,
0,
3
] |
NCT02715583 | 1:23:treatment, | Cytotoxic chemotherapy within 4 weeks prior to study enrollment | 3 | [
"Cytotoxic",
"chemotherapy",
"within",
"4",
"weeks",
"prior",
"to",
"study",
"enrollment"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02332369 | 180:206:chronic_disease,208:224:chronic_disease,226:232:chronic_disease | patient has observed or suspected weakened, torn, missing or otherwise compromised zonules (torn or missing estimated not to exceed one-third of the capsular bag diameter) due to Pseudoexfoliation Syndrome, Marfans Syndrome, trauma or other zonular compromising condition | 3 | [
"patient",
"has",
"observed",
"or",
"suspected",
"weakened",
",",
"torn",
",",
"missing",
"or",
"otherwise",
"compromised",
"zonules",
"(",
"torn",
"or",
"missing",
"estimated",
"not",
"to",
"exceed",
"one-third",
"of",
"the",
"capsular",
"bag",
"diameter",
")... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0
] |
NCT02171104 | 1:33:chronic_disease | D-Bifunctional enzyme deficiency | 3 | [
"D-Bifunctional",
"enzyme",
"deficiency"
] | [
2,
2,
2
] |
NCT01011777 | 23:37:treatment,72:87:treatment,91:97:treatment | Previous injection of bulking agents at the level of the bladder neck (bovine collagen or DEFLUX™) | 3 | [
"Previous",
"injection",
"of",
"bulking",
"agents",
"at",
"the",
"level",
"of",
"the",
"bladder",
"neck",
"(",
"bovine",
"collagen",
"or",
"DEFLUX™",
")"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0
] |
NCT02533674 | ,32:34:chronic_disease | Recovery to grade ≤ 1 from any AE derived from previous treatment | 3 | [
"Recovery",
"to",
"grade",
"≤",
"1",
"from",
"any",
"AE",
"derived",
"from",
"previous",
"treatment"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT02150967 | 15:61:cancer | Patients with cancers of the gallbladder or ampulla of Vater | 3 | [
"Patients",
"with",
"cancers",
"of",
"the",
"gallbladder",
"or",
"ampulla",
"of",
"Vater"
] | [
0,
0,
3,
3,
3,
3,
3,
3,
3,
3
] |
NCT03148795 | 1:20:chronic_disease | Soft tissue disease progression as defined by RECIST 1.1 | 3 | [
"Soft",
"tissue",
"disease",
"progression",
"as",
"defined",
"by",
"RECIST",
"1.1"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02389465 | 1:23:chronic_disease | Severe Medical problem, which in the opinion of the investigator would pose a safety risk to the subject | 3 | [
"Severe",
"Medical",
"problem",
",",
"which",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
"would",
"pose",
"a",
"safety",
"risk",
"to",
"the",
"subject"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.